StockData
Immuron Ltd logo

Immuron Ltd (IMRN) stock

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.85−0.02 (-1.88%)

Close on Nov 19, 2026Market cap $6.86MP/E –Yield –

Immuron free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2026 it was -A$3.26M. The highest annual figure on record is -A$1.80M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-A$3.26M–
FY2024Jun 30, 2024-A$5.88M–
FY2023Jun 30, 2023-A$2.60M–
FY2022Jun 30, 2022-A$3.16M–
FY2021Jun 30, 2021-A$4.09M–
FY2020Jun 30, 2020-A$3.15M–
FY2019Jun 30, 2019-A$1.80M–
FY2018Jun 30, 2018-A$3.51M–
FY2017Jun 30, 2017-A$6.95M–
FY2016Jun 30, 2016-A$5.16M–

More Immuron figures

See a number that looks wrong?